201 related articles for article (PubMed ID: 25576059)
21. FoxO1 integrates direct and indirect effects of insulin on hepatic glucose production and glucose utilization.
O-Sullivan I; Zhang W; Wasserman DH; Liew CW; Liu J; Paik J; DePinho RA; Stolz DB; Kahn CR; Schwartz MW; Unterman TG
Nat Commun; 2015 May; 6():7079. PubMed ID: 25963540
[TBL] [Abstract][Full Text] [Related]
22. Foxo1 integrates insulin signaling with mitochondrial function in the liver.
Cheng Z; Guo S; Copps K; Dong X; Kollipara R; Rodgers JT; Depinho RA; Puigserver P; White MF
Nat Med; 2009 Nov; 15(11):1307-11. PubMed ID: 19838201
[TBL] [Abstract][Full Text] [Related]
23. Dual role of transcription factor FoxO1 in controlling hepatic insulin sensitivity and lipid metabolism.
Matsumoto M; Han S; Kitamura T; Accili D
J Clin Invest; 2006 Sep; 116(9):2464-72. PubMed ID: 16906224
[TBL] [Abstract][Full Text] [Related]
24. Molecular Mechanism of Betaine on Hepatic Lipid Metabolism: Inhibition of Forkhead Box O1 (FoxO1) Binding to Peroxisome Proliferator-Activated Receptor Gamma (PPARγ).
Kim DH; Lee B; Kim MJ; Park MH; An HJ; Lee EK; Chung KW; Park JW; Yu BP; Choi JS; Chung HY
J Agric Food Chem; 2016 Sep; 64(36):6819-25. PubMed ID: 27546313
[TBL] [Abstract][Full Text] [Related]
25. Foxo1 mediates insulin action on apoC-III and triglyceride metabolism.
Altomonte J; Cong L; Harbaran S; Richter A; Xu J; Meseck M; Dong HH
J Clin Invest; 2004 Nov; 114(10):1493-503. PubMed ID: 15546000
[TBL] [Abstract][Full Text] [Related]
26. Alpha-lipoic acid induces adipose triglyceride lipase expression and decreases intracellular lipid accumulation in HepG2 cells.
Kuo YT; Lin TH; Chen WL; Lee HM
Eur J Pharmacol; 2012 Oct; 692(1-3):10-8. PubMed ID: 22819708
[TBL] [Abstract][Full Text] [Related]
27. Nuclear forkhead box O1 controls and integrates key signaling pathways in hepatocytes.
Naïmi M; Gautier N; Chaussade C; Valverde AM; Accili D; Van Obberghen E
Endocrinology; 2007 May; 148(5):2424-34. PubMed ID: 17303659
[TBL] [Abstract][Full Text] [Related]
28. Upregulation of lncRNA MEG3 promotes hepatic insulin resistance via increasing FoxO1 expression.
Zhu X; Wu YB; Zhou J; Kang DM
Biochem Biophys Res Commun; 2016 Jan; 469(2):319-25. PubMed ID: 26603935
[TBL] [Abstract][Full Text] [Related]
29. FoxO1 Is Required for Most of the Metabolic and Hormonal Perturbations Produced by Hepatic Insulin Receptor Deletion in Male Mice.
Ling AV; Gearing ME; Semova I; Shin DJ; Clements R; Lai ZW; Biddinger SB
Endocrinology; 2018 Mar; 159(3):1253-1263. PubMed ID: 29300910
[TBL] [Abstract][Full Text] [Related]
30. USP7 attenuates hepatic gluconeogenesis through modulation of FoxO1 gene promoter occupancy.
Hall JA; Tabata M; Rodgers JT; Puigserver P
Mol Endocrinol; 2014 Jun; 28(6):912-24. PubMed ID: 24694308
[TBL] [Abstract][Full Text] [Related]
31. Wnt signaling regulates hepatic metabolism.
Liu H; Fergusson MM; Wu JJ; Rovira II; Liu J; Gavrilova O; Lu T; Bao J; Han D; Sack MN; Finkel T
Sci Signal; 2011 Feb; 4(158):ra6. PubMed ID: 21285411
[TBL] [Abstract][Full Text] [Related]
32. Genome-wide analysis of FoxO1 binding in hepatic chromatin: potential involvement of FoxO1 in linking retinoid signaling to hepatic gluconeogenesis.
Shin DJ; Joshi P; Hong SH; Mosure K; Shin DG; Osborne TF
Nucleic Acids Res; 2012 Dec; 40(22):11499-509. PubMed ID: 23066095
[TBL] [Abstract][Full Text] [Related]
33. FOXO1-dependent up-regulation of MAP kinase phosphatase 3 (MKP-3) mediates glucocorticoid-induced hepatic lipid accumulation in mice.
Feng B; He Q; Xu H
Mol Cell Endocrinol; 2014 Aug; 393(1-2):46-55. PubMed ID: 24946098
[TBL] [Abstract][Full Text] [Related]
34. Forkhead box protein O1 (FoxO1) regulates hepatic serine protease inhibitor B1 (serpinB1) expression in a non-cell-autonomous fashion.
El Ouaamari A; O-Sullivan I; Shirakawa J; Basile G; Zhang W; Roger S; Thomou T; Xu S; Qiang G; Liew CW; Kulkarni RN; Unterman TG
J Biol Chem; 2019 Jan; 294(3):1059-1069. PubMed ID: 30459233
[TBL] [Abstract][Full Text] [Related]
35. FoxO1: mute for a tuned metabolism?
Cheng Z
Trends Endocrinol Metab; 2015 Aug; 26(8):402-3. PubMed ID: 26170190
[TBL] [Abstract][Full Text] [Related]
36. Targeting foxo1 in mice using antisense oligonucleotide improves hepatic and peripheral insulin action.
Samuel VT; Choi CS; Phillips TG; Romanelli AJ; Geisler JG; Bhanot S; McKay R; Monia B; Shutter JR; Lindberg RA; Shulman GI; Veniant MM
Diabetes; 2006 Jul; 55(7):2042-50. PubMed ID: 16804074
[TBL] [Abstract][Full Text] [Related]
37. Increased expression and activity of the transcription factor FOXO1 in nonalcoholic steatohepatitis.
Valenti L; Rametta R; Dongiovanni P; Maggioni M; Fracanzani AL; Zappa M; Lattuada E; Roviaro G; Fargion S
Diabetes; 2008 May; 57(5):1355-62. PubMed ID: 18316359
[TBL] [Abstract][Full Text] [Related]
38. Direct Hepatocyte Insulin Signaling Is Required for Lipogenesis but Is Dispensable for the Suppression of Glucose Production.
Titchenell PM; Quinn WJ; Lu M; Chu Q; Lu W; Li C; Chen H; Monks BR; Chen J; Rabinowitz JD; Birnbaum MJ
Cell Metab; 2016 Jun; 23(6):1154-1166. PubMed ID: 27238637
[TBL] [Abstract][Full Text] [Related]
39. Menin regulates lipid deposition in mouse hepatocytes via interacting with transcription factor FoxO1.
Wang S; Liu T; Sun L; Du H; Xu Z; Li R; Yu Y; Mao Y; Shi K
Mol Cell Biochem; 2022 May; 477(5):1555-1568. PubMed ID: 35182330
[TBL] [Abstract][Full Text] [Related]
40. Foxa2 regulates lipid metabolism and ketogenesis in the liver during fasting and in diabetes.
Wolfrum C; Asilmaz E; Luca E; Friedman JM; Stoffel M
Nature; 2004 Dec; 432(7020):1027-32. PubMed ID: 15616563
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
